- Home
- WIMI vs LGVN Comparison
WIMI vs LGVN Comparison
Compare WIMI & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- LGVN
- Stock Information
- Founded
- WIMI 2015
- LGVN 2014
- Country
- WIMI China
- LGVN United States
- Employees
- WIMI 107
- LGVN N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- WIMI Technology
- LGVN Health Care
- Exchange
- WIMI Nasdaq
- LGVN Nasdaq
- Market Cap
- WIMI 23.9M
- LGVN 23.4M
- IPO Year
- WIMI 2020
- LGVN 2021
- Fundamental
- Price
- WIMI $3.69
- LGVN $1.53
- Analyst Decision
- WIMI
- LGVN Strong Buy
- Analyst Count
- WIMI 0
- LGVN 3
- Target Price
- WIMI N/A
- LGVN $8.67
- AVG Volume (30 Days)
- WIMI 7.6M
- LGVN 723.5K
- Earning Date
- WIMI 01-01-0001
- LGVN 08-13-2025
- Dividend Yield
- WIMI N/A
- LGVN N/A
- EPS Growth
- WIMI N/A
- LGVN N/A
- EPS
- WIMI N/A
- LGVN N/A
- Revenue
- WIMI $84,137,968.00
- LGVN $2,225,000.00
- Revenue This Year
- WIMI N/A
- LGVN N/A
- Revenue Next Year
- WIMI N/A
- LGVN $51.48
- P/E Ratio
- WIMI N/A
- LGVN N/A
- Revenue Growth
- WIMI 19.25
- LGVN 127.50
- 52 Week Low
- WIMI $0.27
- LGVN $1.14
- 52 Week High
- WIMI $2.92
- LGVN $4.88
- Technical
- Relative Strength Index (RSI)
- WIMI 65.38
- LGVN 62.48
- Support Level
- WIMI $3.15
- LGVN $1.37
- Resistance Level
- WIMI $3.75
- LGVN $1.52
- Average True Range (ATR)
- WIMI 0.30
- LGVN 0.12
- MACD
- WIMI 0.13
- LGVN 0.02
- Stochastic Oscillator
- WIMI 97.04
- LGVN 66.67
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.